1 / 51

Lindsey VanderBusch STD/HIV/TB/Hepatitis Program Manager Sarah Weninger, MPH

Sexually Transmitted Disease Epidemiology in North Dakota Chlamydia, Gonorrhea, Hepatitis C, Syphilis and HIV. Lindsey VanderBusch STD/HIV/TB/Hepatitis Program Manager Sarah Weninger, MPH Viral Hepatitis and STD Program Coordinator. Reported Chlamydia by Sex North Dakota, 2012 -2013.

len-griffin
Download Presentation

Lindsey VanderBusch STD/HIV/TB/Hepatitis Program Manager Sarah Weninger, MPH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Sexually Transmitted Disease Epidemiology in North DakotaChlamydia, Gonorrhea, Hepatitis C, Syphilis and HIV Lindsey VanderBusch STD/HIV/TB/Hepatitis Program Manager Sarah Weninger, MPH Viral Hepatitis and STD Program Coordinator

  2. Reported Chlamydia by SexNorth Dakota, 2012 -2013

  3. Reported Cases of Chlamydia by Age GroupNorth Dakota, 2012 -2013

  4. Chlamydia Rates by Race/EthnicityNorth Dakota, 2012 - 2013 *Person of Hispanic ethnicity may be of any race; 22% of Chlamydia cases have unknown race

  5. 2012 Chlamydia: Geographic Map

  6. 2013 Chlamydia: Geographic Map

  7. Changes from 2012-2013; Chlamydia

  8. Chlamydia Follow-Up • Conduct Partner Services for Cases who are <14 years, pregnant or who have PID • Patient Dispositions • A. Infectious Brought to Treatment • 2798 (95%) • B. Infectious No Treatment • 131 (5%): 6% American Indian, 15% White, 79% Unknown Race

  9. Reported Gonorrhea by SexNorth Dakota, 2012 - 2013

  10. Reported Cases of Gonorrhea by Age Group; North Dakota, 2012 – 2013

  11. Gonorrhea Rates by Race/EthnicityNorth Dakota, 2012 - 2013 *Person of Hispanic ethnicity may be of any race For 2013, 15.6% of GC Cases have unknown race

  12. Gonorrhea Rates by Race, 2009-2013

  13. GC Rate by County, 2009-2013

  14. 2012 Gonorrhea – ND Map

  15. 2013 Gonorrhea – ND Map

  16. Changes from 2012-2013

  17. Gonorrhea Follow-Up • Field Staff Conduct Investigations on all GC Cases • Patient Dispositions • A. Infectious Brought to Treatment • 407 (84.4%) • B. Infectious No Treatment • 75 (15.6%): 3% Black, 5% American Indian, 11% White, 81% Unknown Race

  18. 13 Primary & Secondary Cases • 2 Females, 11 Males • 7 American Indians, 3 White, 2 Black, 1 Asian • 13 Latent Cases 2013* Syphilis is North Dakota

  19. 2012 Syphilis – ND Map – Early and Latent Syphilis

  20. 2013 Syphilis – ND Map – Early and Latent Syphilis

  21. Changes from 2012-2013

  22. Syphilis Outbreak, ND-SD 2013-14

  23. Syphilis Outbreak, ND-SD 2013-14

  24. Syphilis Outbreak, ND-SD 2013-14

  25. Enhanced Screening Recommendations • All high-risk pregnant women in North Dakota should be screened for syphilis at least three times during the course of pregnancy. This recommendation is made by CDC for areas experiencing high syphilis morbidity. Currently Sioux County in North Dakota qualifies as an area with high syphilis morbidity. • Screen 1 should occur at a patient’s first prenatal visit; • Screen 2 should occur in the third trimester (between 28-32 weeks) and • Screen 3 should occur on the day of delivery. Three screens are essential, even if the first screen is negative. If a woman tests positive, refer to the Treatment Guidelines (link below) for information on treating both mother and child. Any woman who delivers a stillborn infant after 20 weeks gestation should be tested for syphilis, regardless of risk. No infant should leave the hospital without the serological status of the mother having been determined at least once during pregnancy. • All persons that have a positive Chlamydia or Gonorrhea test or • Residents of Sioux County, between the ages of 15 and 50 who are sexually active or • Patients who have sexual partners from Sioux County or • Men who have sex with men or • All patients with ano-genital lesions or • All patients with oral lesions suggestive of a primary syphilitic chancre or • All patients presenting with a rash, especially palmar or plantar rashes,alopecia or • gummatous lesions • Patients with neurological signs or symptoms of unknown cause and syphilis has not yet been ruled out.

  26. Syphilis Testing • RPR—non-treponmal test • Followed by antibody titer • Example (1:32 or 1:128) • FTA or TP-PA—treponmal • Syphilis is confirmed

  27. Syphilis Treatment • Benzathine penicillin G (i.e., Bicillin, LA™) remains the preferred treatment for syphilis.

  28. Syphilis Staging • Primary • Primary lesion or chancre • Often painless • Chancre is contagious • Secondary • Usually presents as a rash that may take on several different appearances. • The rash may appear as rough, red or reddish brown spots may be found on the palms of the hand or the soles of the feet and usually does not cause itching. • “Great imitator” • Fever, swollen lymph glands, sore throat, patchy hair loss, headaches, weight loss, muscle aches and fatigue. • Latent Stages • Usually asymptomatic • Visual Case Analysis done to determine evaluation of sex partners based on staging done by ND DIS.

  29. Syphilis Treatment cont. • Non-pregnant persons infected with syphilis in whom penicillin is contradicted can be treated with alternative regimens, depending on the stage of syphilis diagnosed. Alternative regimens consist of oral doxycycline or tetracycline and require two to four weeks of treatment. Compliance with these regimens must be monitored. • Sexual Contacts: • For the management of sexual contacts of infected individuals, testing and treatment depends on the stage of the index case. • Presumptive treatment, along with testing, should be given to persons exposed to primary, secondary, early latent syphilis or to those exposed to individuals with latent syphilis of unknown duration with high titers (i.e. 1:32). • Partners exposed to an unknown stage of syphilis should be tested and treated presumptively. Long-term sex partners of patients who have latent syphilis should be evaluated clinically and serologically for syphilis and treated on the basis of the evaluation findings.

  30. Reported Hepatitis C Cases* by YearNorth Dakota, 2009-2013 * Includes acute and “past or present” infections

  31. North Dakota Hepatitis C Cases* by Gender, 2012 - 2013 * Includes acute and “past or present” infections

  32. North Dakota Hepatitis C Cases* by Age Group, 2012 - 2013 * Includes acute and “past or present” infections

  33. North Dakota Hepatitis C Cases* by Race, 2012 - 2013 * Includes acute and “past or present” infections

  34. HIV in North Dakota, 2009 - 2013

  35. Living in North Dakota with HIV/AIDS, n=357

  36. Living in North Dakota by Gender, n=357

  37. Number Living in North Dakota by Age, n=357

  38. Living in North Dakota by Race/Ethnicity, n=357

  39. Living in North Dakota by Risk Factor n=357

  40. 2009 – 2013HIV/AIDS Status at Time of Diagnosis in ND

  41. 2009-2013 Gender of Cases at Time of Diagnosis in ND

  42. 2009 – 2013; Risk Factor by Gender

  43. 2009 – 2013: Male Risk Factors by Race

  44. 2009 – 2013: Female Risk Factors by Race

  45. 2009-2013: Race/Ethnicity of HIV/AIDS Cases

  46. 2009-2013: Disparity by Race

  47. HIV CTR Data 2013 • 4133 Tested: 81.5% White, 7.5% American Indian • White: 56% of Total Number Tested were Female • American Indian: 63% of Total Number Tested were Female Risk Factors • Injection Drug Use: 5.9% Whites; 16.6% American Indian • Had Sex Without a Condom: 90% Whites, 90% American Indian • Had Sex with Anonymous Partners: 13% Whites, 17% American Indians • MSM: 17% of White Males; 8% of American Indian Males

More Related